The results showed that regardless of whether the tumor was low-grade or high-grade, the progression-free survival probability of the IL7R-high expression group was significantly lower than that of the IL7R-low expression group; moreover, the statistical significance of this difference was more pronounced in high-grade patients. Here, IL7R is linked to neoplasm.